Have a personal or library account? Click to login
Locoregional disease control after external beam radiotherapy in 91 patients with differentiated thyroid carcinoma and pT4 tumor stage - a single institution experience Cover

Locoregional disease control after external beam radiotherapy in 91 patients with differentiated thyroid carcinoma and pT4 tumor stage - a single institution experience

Radiology and Oncology
Volume 52 (2018): Issue 4 (December 2018)
By: Nikola Besic,  Marta Dremelj and  Gasper Pilko  
Open Access
|Sep 2018

References

  1. Schlumberger MJ. Papillary and follicular thyroid carcinoma. N Engl J Med 1998; 338: 297-306. 10.1056/NEJM199801293380506Table
    Open DOISearch in Google ScholarBack to article
  2. Chow SM, Law SCK, Mendenhall WM, Au SK, Chan PT, Leung TW, et al. Papillary thyroid carcinoma: prognostic factors and the role of radioiodine and external radiotherapy. Int J Radiat Oncol Biol Phys 2002; 52: 784-95. org/10.1016/S0360-3016(01)02686-4Table
    Open DOISearch in Google ScholarBack to article
  3. Brierley J, Tsang R, Panzarella T, Bana N. Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years. Clin Endocrinol (Oxf) 2005; 63: 418-27. 10.1111/j.1365-2265.2005.02358.xTable
    Open DOISearch in Google ScholarBack to article
  4. Kim JH, Leeper RD. Treatment of locally advanced thyroid carcinoma with combination doxorubicin and radiation therapy. Cancer 1987; 60: 2372-5. Table
    Search in Google ScholarBack to article
  5. Philips P, Hansen C, Andry G, Van Houtte P, Früuling J. Postoperative irradiation for thyroid cancer. Eur J Surg Oncol 1993; 19: 399-404.Table
    Search in Google ScholarBack to article
  6. Farahati J, Reiners C, Stuschke M, Müller SP, Stüben G, Sauerwein W, Sack H. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4). Cancer 1996; 77: 172-80. 10.1002/(SICI)1097-0142(19960101)77:1<;172::AID-CNCR28>3.0.CO;2-1Table
    Open DOISearch in Google ScholarBack to article
  7. Tsang RW, Brierley JD, Simpson WJ, Panzarella T, Gospodarowicz MK, Sutcliffe SB. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Cancer 1998; 82: 375-88 .Table
    Search in Google ScholarBack to article
  8. Rosenbluth BD, Serrano V, Happersett L, Shaha AR, Tuttle RM, Narayana A, et al. Intensity-modulated radiation therapy for the treatment of nonanaplastic thyroid cancer. Int J Radiat Oncol Biol Phys 2005; 63: 1419-26. 10.1016/j.ijrobp.2005.05.043Table
    Open DOISearch in Google ScholarBack to article
  9. Chow SM, Yau S, Kwan CK, Poon PC, Law SC. Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition. Endocr Relat Cancer 2006; 13: 1159-72. 10.1677/erc.1.01320Table
    Open DOISearch in Google ScholarBack to article
  10. Azrif M, Slevin NJ, Sykes AJ, Swindell R, Yap BK. Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation. Radiother Oncol 2008; 89: 105-13. 10.1016/j.radonc.2008.05.023Table
    Open DOISearch in Google ScholarBack to article
  11. Terezakis SA, Lee KS, Ghossein RA, Rivera M, Tuttle RM, Wolden SL, et al. Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys 2009; 73: 795-801. 10.1016/j.ijrobp.2008.05.012Table
    Open DOISearch in Google ScholarBack to article
  12. Schwartz DL, Lobo MJ, Ang KK, Morrison WH, Rosenthal DI, Ahamad A, et al. Postoperative external beam radiotherapy for differentiated thyroid cancer: outcomes and morbidity with conformal treatment. Int J Radiat Oncol Biol Phys 2009; 74: 1083-91. 10.1016/j.ijrobp.2008.09.023Table
    Open DOISearch in Google ScholarBack to article
  13. Biermann M, Pixberg M, Riemann B, Schuck A, Heinecke A, Schmid KW, et al; MSDS study group. Clinical outcomes of adjuvant external-beam radiotherapy for differentiated thyroid cancer - results after 874 patient-years of follow-up in the MSDS-trial. Nuklearmedizin 2009; 48: 89-98. 10.3413/nukmed-0221Table
    Open DOISearch in Google ScholarBack to article
  14. Kim TH, Chung KW, Lee YJ, Park CS, Lee EK, Kim TS, et al. The effect of external beam radiotherapy volume on locoregional control in patients with locoregionally advanced or recurrent nonanaplastic thyroid cancer. Radiat Oncol 2010; 5: 69. 10.1186/1748-717X-5-69Table
    Open DOISearch in Google ScholarBack to article
  15. Cancer in Slovenia 2014. Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia, 2017. [cited 2018 April 15]. Available from: https://www.onko-i.si/filead-min/onko/datoteke/dokumenti/RRS/LP_2014.pdfTable
    Search in Google ScholarBack to article
  16. Rosai J. Tumors of thyroid gland. In: Rosai J, Carcangiu ML, DeLellis RA, editors. Atlas of tumor pathology. Washington: Armed Forces Institute of Pathology; 1992. p. 31-50.Table
    Search in Google ScholarBack to article
  17. LiVolsi VA, Baloch ZW. Follicular neoplasms of the thyroid: view, biases, and experiences. Adv Anat Pathol 2004; 11: 279-87. 10.1097/01.pap.0000138143.34505.02Table
    Open DOISearch in Google ScholarBack to article
  18. Sobin LH, Gospodarowicz MK, Wittekind C. Thyroid gland (ICD-O C73). In: Sobin LH, Gospodarowicz MK, Witekind C, editors. TNM classification of malignant tumours. 7th Edition. New York: Wiley Blackwell; 2009. p. 58-62. Table
    Search in Google ScholarBack to article
  19. Zagar I, Schwarzbartl-Pevec A, Vidergar-Kralj B, Horvat R, Besic N. Recombinant human thyrotropin-aided radioiodine therapy in patients with metastatic differentiated thyroid carcinoma. J Thyroid Res 2012; 670180. 10.1155/2012/670180Table
    Open DOISearch in Google ScholarBack to article
  20. Vassilopoulou-Sellin R, Schultz PN, Haynie TP. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy. Cancer 1996; 78: 493-501. 10.1002/(SICI)1097-0142(19960801)78:3<;493::AID-CNCR17>3.0.CO;2-UTable
    Open DOISearch in Google ScholarBack to article
  21. Feig BW, Ching DC editors. The MD Anderson surgical oncology handbook. Philadelphia: Lippincott Williams & Wilkins; 2012.Table
    Search in Google ScholarBack to article
  22. Santini F, Bottici V, Elisei R, Montanelli L, Mazzeo S, Basolo F, et al. Cytotoxic effects of carboplatinum and epirubicin in the setting of an elevated serum thyrotropin for advanced poorly-differentiated thyroid cancer. J Clin Endocrinol Metab 2002; 87: 4160-5. 10.1210/jc.2001-011151Table
    Open DOISearch in Google ScholarBack to article
  23. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016; 26: 1-133. 10.1089/thy.2015.0020Table
    Open DOISearch in Google ScholarBack to article
  24. Brierley JD. Update on external beam radiation therapy in thyroid cancer. J Clin Endocrinol Metab 2011; 96: 2289-95. 10.1210/jc.2011-1109Table
    Open DOISearch in Google ScholarBack to article
  25. Besic N, Auersperg M, Gazic B, Dremelj M, Zagar I. Neoadjuvant chemotherapy in 29 patients with locally advanced follicular or Hürthle cell thyroid carcinoma: a phase 2 study. Thyroid 2012; 22: 131-7. 10.1089/thy.2011.0243Table
    Open DOISearch in Google ScholarBack to article
  26. Besic N, Auersperg M, Dremelj M, Vidergar-Kralj B, Gazic B. Neoadjuvant chemotherapy in 16 patients with locally advanced papillary thyroid carcinoma. Thyroid 2013; 23: 178-84. 10.1089/thy.2012.0194Table
    Open DOISearch in Google ScholarBack to article
  27. Besic N, Dremelj M, Schwartzbartl-Pevec A, Gazic B. Neoadjuvant chemotherapy in 13 patients with locally advanced poorly differentiated thyroid carcinoma based on Turin proposal - a single institution experience. Radiol Oncol 2015; 49: 271-8. 10.1515/raon-2015-0001Table
    Open DOISearch in Google ScholarBack to article
  28. Vogrin A, Besic H, Besic N, Music MM. Recurrence rate in regional lymph nodes in 737 patients with follicular or Hürthle cell neoplasms. Radiol Oncol 2016; 50: 269-73. 10.1515/raon-2016-0025
    Open DOISearch in Google ScholarBack to article
DOI: https://doi.org/10.2478/raon-2018-0038 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 453 - 460
Submitted on: May 4, 2018
|
Accepted on: May 23, 2018
|
Published on: Sep 22, 2018
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
thyroid carcinoma,
radiotherapy,
survival,
pathology,
locoregional recurrence
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2018 Nikola Besic, Marta Dremelj, Gasper Pilko, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 52 (2018): Issue 4 (December 2018)Next article